Crescent Biopharma, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CBIO, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
9
Funds holding
$8799152
Total value held
Buying
6 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Goldman Sachs Group Inc | $4197086 | 228475 | +203230 | +805.03% |
| 2 | Blackrock, Inc. | $2125869 | 115725 | +6495 | +5.95% |
| 3 | State Street Corp | $717661 | 39067 | +12850 | +49.01% |
| 4 | Barclays Plc | $554572 | 30189 | — | NEW BUY |
| 5 | Bank Of America Corp /De/ | $537818 | 29277 | +23704 | +425.34% |
| 6 | Morgan Stanley | $341260 | 18577 | -8944 | -32.50% |
| 7 | Northern Trust Corp | $316497 | 17229 | — | Held |
| 8 | Citigroup Inc | $7389 | 623 | -175 | -21.93% |
| 9 | Royal Bank Of Canada | $1000 | 51 | — | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.